SARILUMAB AS MONOTHERAPY OR IN COMBINATION WITH CONVENTIONAL SYNTHETIC DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: 12-WEEK TREATMENT RESULTS FROM A MULTICENTER, OPEN-LABEL, PROSPECTIVE, SINGLE-ARM OBSERVATIONAL STUDY

被引:0
|
作者
Kivitz, A. [1 ]
Gottenberg, J. E. [2 ]
Bergman, M. [3 ]
Iglesias-Rodriguez, M. [4 ]
St John, G. [5 ]
Qiu, C. [6 ]
Van Hoogstraten, H. [6 ]
Bessette, L. [7 ]
机构
[1] Altoona Ctr Clin Res, Duncansville, PA USA
[2] Hop Univ Strasbourg, Strasbourg, France
[3] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[4] Sanofi Genzyme, Cambridge, MA USA
[5] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[6] Sanofi, Bridgewater, NJ USA
[7] Laval Univ, Quebec City, PQ, Canada
关键词
D O I
10.1136/annrheumdis-2020-eular.1972
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0301
引用
收藏
页码:1446 / 1446
页数:1
相关论文
共 50 条
  • [31] Evocalcet in patients with primary hyperparathyroidism: an open-label, single-arm, multicenter, 52-week, dose-titration phase III study
    Yasuhiro Takeuchi
    Yuichi Nishida
    Yuichiro Kondo
    Yasuo Imanishi
    Seiji Fukumoto
    Journal of Bone and Mineral Metabolism, 2020, 38 : 687 - 694
  • [32] Depression is as Early Complication of HCV Treatment: Results From EMPOWER (a Randomized, Open-Label 12-Week Comparison in 133 Patients)
    Long, Walker A.
    Takov, Dimitar V.
    Tchernev, Konstantin
    Krastev, Zahary
    Lawitz, Eric J.
    Lurie, Yoav
    Kotzev, Iskren A.
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2012, 142 (05) : S961 - S961
  • [33] Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia
    O'Brien, Maureen M.
    Alonzo, Todd A.
    Cooper, Todd M.
    Levine, John E.
    Brown, Patrick A.
    Slone, Tamra
    August, Keith J.
    Benettaib, Bouchra
    Biserna, Noha
    Poon, Jennifer
    Patturajan, Meera
    Chen, Nianhang
    Simcock, Mathew
    Zimmerman, Linda
    Kolb, E. Anders
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
  • [34] Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study
    Matsueda, Kei
    Fukudo, Shin
    Ogishima, Masayuki
    Naito, Yuki
    Nakamura, Soichiro
    BIOPSYCHOSOCIAL MEDICINE, 2024, 18 (01)
  • [35] Efficacy and safety of peppermint oil for the treatment in Japanese patients with irritable bowel syndrome: a prospective, open-label, and single-arm study
    Kei Matsueda
    Shin Fukudo
    Masayuki Ogishima
    Yuki Naito
    Soichiro Nakamura
    BioPsychoSocial Medicine, 18
  • [36] Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenstrom's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results
    Cao, Xinxin
    Jin, Jie
    Cheng, Fu Cheng
    Yi, Shuhua
    Zhao, Weili
    Sun, Zimin
    Yang, Wei
    Li, Dengju
    Cui, Guohui
    Hu, Jianda
    Liu, Ting
    Song, Yongping
    Xu, Bing
    Zhu, Zunmin
    Xu, Wei
    Zhang, Mingzhi
    Li, Sichen
    Wang, Weige
    Zhao, Renbin
    Zhou, Daobin
    BLOOD, 2023, 142
  • [37] Alteplase for the treatment of central venous catheter occlusion in children: Results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study)
    Blaney, Martha
    Shen, Violet
    Kerner, John A.
    Jacobs, Brian R.
    Gray, Sarah
    Armfield, Jennifer
    Semba, Charles P.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (11) : 1745 - 1751
  • [38] EFFECTIVENESS OF DIFFERENT SCHEMES OF ETORICOXIB ADMINISTRATION IN REDUCTION OF ACTIVE SACROILIITIS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS - RESULTS OF A 12-WEEK, PROSPECTIVE, OPEN-LABEL STUDY
    Gaydukova, I.
    Rebrov, A. P.
    Akulova, A. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 282 - 282
  • [39] Effects of galcanezumab on central sensitization in migraine patients: A prospective, open-label, single-arm multicenter study using validated central sensitization inventory
    Danno, Daisuke
    Imai, Noboru
    Kitamura, Shigekazu
    Ishizaki, Kumiko
    Kikui, Shoji
    Takeshima, Takao
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [40] A single-arm, open-label, prospective, multicenter study of apatinib combined with chemotherapy as second-line therapy in patients with advanced gastric cancer
    Feng, J.
    Shen, B.
    Xu, J.
    Wang, Q.
    Ling, G.
    Mao, Y.
    Cai, M.
    Yang, Y.
    Mei, J.
    Han, Z.
    Wu, Y.
    Shi, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S913 - S913